Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› GangnamGu
Clinical trial register · South Korea

Clinical Trials in GangnamGu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3401 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
3401
Studies in scope
all four open statuses
1867
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Seoul 2859 Daegu 553 Seongnam-si 482 Busan 469 Goyang-si 397
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
BeOne Medicines14
Target enrolment
to

Trials with a site in GangnamGu

14 of 3401 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
BeOne Medicines
Phase 3
351
Seongnam-si, BukGu, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-08-27
Recruiting
BeOne Medicines
Phase 3
300
Seogu, GangnamGu, SeochoGu, Seoul, SongpaGu, Yeongdeungpo-gu
2025-03-05
Recruiting
BeOne Medicines
Phase 1
695
PaldalGu SuwonSi, Seongnam-si, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-01-10
Recruiting
BeOne Medicines
Phase 1
168
BundangGu SeongnamSi, Seongnam-si, BukGu, NamdongGu, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2024-12-09
Recruiting
BeOne Medicines
Phase 1
153
PaldalGu SuwonSi, Seongnam-si, GangnamGu, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2024-10-18
Recruiting
BeOne Medicines
Phase 1
310
Seongnam-si, GangnamGu, SeodaemunGu, SongpaGu
2024-10-03
Recruiting
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
NCT06427941Metastatic Hepatocellular Carcinoma, Local Advanced Hepatocellular Carcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Extragonadal Yolk Sac Tumors
BeOne Medicines
Phase 1/2
630
Cheongju-si, BundangGu SeongnamSi, Seongnam-si, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2024-07-23
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
BeOne Medicines
Phase 1
433
Seongnam-si, NamdongGu, GangnamGu, SeochoGu, SeodaemunGu, SeongbukGu, Seoul, SongpaGu
2023-12-01
Active, closed
BeOne Medicines
Phase 3
799
BusanjinGu, Seogu, Seongnam-si, BukGu, Jinju, HwasunGun, GangnamGu, SeochoGu
2022-03-10
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
BeOne Medicines
Phase 1/2
689
Seogu, GangnamGu, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2021-09-13
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
BeOne Medicines
Phase 1/2
260
GangnamGu, SeodaemunGu
2021-05-24
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/gangnamgu

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,401 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in GangnamGu.

How many clinical trials are recruiting in GangnamGu?

13 of the 14 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (GangnamGu), 14 studies
PhaseStudiesRecruitingShare
Phase 15535.7%
Phase 35435.7%
Phase 1/24428.6%

Most active sponsors

Lead sponsors with the most studies (GangnamGu)
Lead sponsorStudiesRecruiting
BeOne Medicines1413
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.